Data compiled by Redley Lamar · ChainSifter Intelligence
4Suppliers
1Customers
2Debt Items
0Related Chains
Source-Backed Evidence Depth
Bioventus Inc. (BVS) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
8Total relationships
2Distinct source URLs
7High confidence
0.855Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Bioventus Inc. Suppliers
Ticker
Name
Confidence
Evidence
SUPPLIER-OF-THE-COMPANY-S-SINGLE-INJECTION-OA-PR
SUPPLIER-OF-THE-COMPANY-S-SINGLE-INJECTION-OA-PR
90%
On December 9, 2016, the Company entered into an amended and restated license agreement for the exclusive U.S. distribution and commercialization rights of a single injection osteoarthritis ("OA") pr…
SUPPLIER-OF-THE-COMPANY-S-FIVE-INJECTION-OA-PROD
SUPPLIER-OF-THE-COMPANY-S-FIVE-INJECTION-OA-PROD
85%
As part of a supply agreement for the Company's five injection OA product that was amended and restated on December 22, 2020, the Company is subject to annual minimum purchase requirements for 8 years.
SUPPLIER-OF-THE-COMPANY-S-THREE-INJECTION-OA-PRO
SUPPLIER-OF-THE-COMPANY-S-THREE-INJECTION-OA-PRO
85%
As part of a supply agreement entered on February 9, 2016 for the Company's three injection OA product, the Company is subject to annual minimum purchase requirements for 10 years.
BV-LLC
BV-LLC
62%
et average selling price (“ASP”) for our EXOGEN Bone Stimulation System. International Net sales increased $2.3 million, or 17.1%, compared to the prior year period, primarily due to volume growth in…
Bioventus Inc. Customers
Ticker
Name
Confidence
Evidence
ONE-CUSTOMER
ONE-CUSTOMER
92%
The Company had product sales to one customer totaling $ 14,822 representing 11.2 % of net sales, primarily in the U.S. reporting segment during the three months ended March 28, 2026.
Bioventus Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
BVS-DEBT-8419
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2022-12-31.
BVS-DEBT
Debt stack $248.5M
90%
Market cache reports total debt of $248.5M.
Bioventus Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Bioventus Inc..
Bioventus Inc. Ownership
Holder
Name
Confidence
Evidence
BVS-OWNER-ESSEX-WOODLANDS-MANAGEMENT-INC
Essex Woodlands Management, Inc.
90%
13F overlay lists Essex Woodlands Management, Inc. as top holder; 157 tracked holders.
Bioventus Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
